glp 1 copay assistance Big change for Medicare beneficiaries: the new GLP-1 Bridge program launches July 2026, covering Wegovy and Zepbound for weight management at a $50 monthly for eligible Part D members Medicare GLP-1 Bridge Program 2026:

Recent employer surveys show: 19% of employers with 200+ employees cover GLP-1s for weight loss 43% of employers with 5,000+ employees provide coverage 64% of employers with 20,000+ employees offer coverage Large employers are increasingly viewing obesity as a chronic condition requiring long-term treatment strategies rather than short-term interventions

Novo also reported an increase of 25 percent in sales in the first half of 2024, totaling 133.4 billion Danish kroner ($27.07 billion)

Glucagon-like peptide-1 receptor agonist semaglutide improves eating behavior and glycemic control in Japanese obese type 2 diabetic patients

Systematic reviews of clinical trial data do not identify myalgia as occurring at significantly higher rates in GLP-1-treated patients compared to placebo groups

That lowers the chance of future tags showing up

of Nursing (July 16, 2024),